HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...
New York, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "ECG Cable & ECG Lead wires Market Research Report by Material, by Machine Type, by Patient Care ...
By ECG lead wire type, the ECG cable & lead wire market is segmented into ECG lead wire and ECG cable. The ECG lead wire market is divided into 12-lead ECG wires, 5-lead ECG wires, 3-lead ECG wires, 6 ...
HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...
FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results